Vanguard Group Inc Vertex Pharmaceuticals Inc Transaction History

Vanguard Group Inc

$6.44 Trillion
Q3 2025

A detailed history of Vanguard Group Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Vanguard Group Inc holds 24,216,865 shares of VRTX stock, worth $10.5 Billion. This represents 0.15% of its overall portfolio holdings.

Number of Shares

24,216,865

Previous 23,973,777 1.01%

Holding current value

$10.5 Billion

Previous $10.7 Billion 11.14%

% of portfolio

0.15%

Previous 0.18%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	BUY	$366.54 - $479.53 $89.1 Million - $117 Million	243,088 Added 1.01%	24,216,865 $9.48 Billion
Q2 2025 Aug 11, 2025	BUY	$421.16 - $509.5 $203 Million - $246 Million	482,616 Added 2.05%	23,973,777 $10.7 Billion
Q1 2025 May 09, 2025	BUY	$402.49 - $513.76 $93.7 Million - $120 Million	232,873 Added 1.0%	23,491,161 $11.4 Billion
Q4 2024 Feb 11, 2025	BUY	$396.64 - $516.74 $39.1 Million - $51 Million	98,654 Added 0.43%	23,258,288 $9.37 Billion
Q3 2024 Nov 13, 2024	BUY	$460.0 - $505.78 $84.7 Million - $93.1 Million	184,113 Added 0.8%	23,159,634 $10.8 Billion
Q2 2024 Aug 13, 2024	BUY	$392.81 - $485.53 $117 Million - $145 Million	299,003 Added 1.32%	22,975,521 $10.8 Billion
Q1 2024 May 10, 2024	BUY	$407.69 - $446.08 $161 Million - $176 Million	394,338 Added 1.77%	22,676,518 $9.48 Billion
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $102 Million - $123 Million	298,824 Added 1.36%	22,282,180 $9.07 Billion
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $29.6 Million - $31.7 Million	87,397 Added 0.4%	21,983,356 $7.64 Billion
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $15.7 Million - $17.5 Million	49,807 Added 0.23%	21,895,959 $7.71 Billion
Q1 2023 Jul 14, 2023	BUY	$283.23 - $323.1 $73,923 - $84,329	261 Added 0.0%	21,846,152 $6.88 Billion
Q1 2023 May 15, 2023	BUY	$283.23 - $323.1 $84.7 Million - $96.6 Million	298,988 Added 1.39%	21,845,891 $6.88 Billion
Q4 2022 Feb 10, 2023	BUY	$285.76 - $321.48 $118 Million - $133 Million	414,567 Added 1.96%	21,546,903 $6.22 Billion
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $80.5 Million - $89.8 Million	293,861 Added 1.41%	21,132,336 $6.12 Billion
Q2 2022 Aug 12, 2022	BUY	$234.96 - $292.55 $85.8 Million - $107 Million	365,004 Added 1.78%	20,838,475 $5.87 Billion
Q1 2022 May 13, 2022	BUY	$221.42 - $260.97 $70.3 Million - $82.9 Million	317,629 Added 1.58%	20,473,471 $5.34 Billion
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $50.8 Million - $64.1 Million	-286,849 Reduced 1.4%	20,155,842 $4.43 Billion
Q3 2021 Nov 12, 2021	BUY	$181.39 - $202.99 $35.1 Million - $39.3 Million	193,473 Added 0.96%	20,442,691 $3.71 Billion
Q2 2021 Aug 13, 2021	BUY	$187.49 - $221.1 $3.8 Billion - $4.48 Billion	20,249,218 New	20,249,218 $4.08 Billion

Others Institutions Holding VRTX

# of Institutions

1,791

Shares Held

231M

Call Options Held

1.84M

Put Options Held

1.21M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $111B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Vertex Pharmaceuticals Inc Transaction History